Trial Profile
Safety and Efficacy of parenteral KGF in moderate asthma subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Palifermin (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 12 Oct 2016 Status changed from recruiting to completed.
- 29 Jun 2011 New source identified and integrated (ClinicalTrials.gov, NCT01386151).
- 29 Jun 2011 Planned End Date changed from 23 Mar 2010 to 1 Jul 2011 as reported by ClinicalTrials.gov.